Showing results (821-830 of 1,044) with videos related to
Sort By:
Pageof 105
Journal of Strength and Conditioning Research|July 13, 2011
Appearance of D2O in sweat after oral and oral-intravenous rehydration in menHolly Emmanuel, Douglas J Casa, Kathleen N Beasley, et al.Hepatology (Baltimore, Md.)|June 18, 2019
Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis DevelopmentJustin D Schumacher, Bo Kong, Jason Wu, et al.Circulation|August 1, 1979
The force-interval relationship of the left ventricleP A Anderson, A Manring, G A Serwer, et al.Journal of Athletic Training|March 10, 2010
The American football uniform: uncompensable heat stress and hyperthermic exhaustionLawrence E Armstrong, Evan C Johnson, Douglas J Casa, et al.Meat Science|July 9, 2018
Novel genetic polymorphisms associated with carcass traits in grazing Texel sheepE Armstrong, G Ciappesoni, W Iriarte, et al.Lancet (London, England)|May 28, 2019
Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 studyJosef S Smolen, Aileen L Pangan, Paul Emery, et al.Journal of Athletic Training|October 23, 2013
Thermoregulation and stress hormone recovery after exercise dehydration: comparison of rehydration methodsBrendon P McDermott, Douglas J Casa, Elaine Lee, et al.The Journal of Heredity|May 29, 2023
Genomic resources for Asian (Elephas maximus) and African savannah elephant (Loxodonta africana) conservation and health researchNatalia A Prado, Ellie E Armstrong, Janine L Brown, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 9, 2016
Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateMark C Genovese, Josef S Smolen, Michael E Weinblatt, et al.Bioorganic & Medicinal Chemistry Letters|January 20, 2007
The synthesis and structure-activity relationship studies of selective acetyl-CoA carboxylase inhibitors containing 4-(thiazol-5-yl)but-3-yn-2-amino motif: polar region modificationsXiangdong Xu, Moshe Weitzberg, Robert F Keyes, et al.Pageof 105